Condition
Coronary Artery Bypass Grafting Surgery
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
80%
4 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (1)
P 3 (2)
P 4 (2)
Trial Status
Completed3
Unknown2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05945303Not ApplicableCompleted
Correlation Between Internal Jugular Vein Ultrasound and Electrical Cardiometry
NCT05361824Phase 4Completed
Ketorolac-an Option for Post Operative Pain Management After Elective Cardiac Surgery.
NCT01046942Phase 3Unknown
ThrombElastoGraphic Haemostatic Status and Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery
NCT01121341Phase 4UnknownPrimary
ESOS (Endoscopic Saphenous Harvesting With an Open CO2 System) Trial
NCT00179491Phase 3CompletedPrimary
Study of the Therapeutic Effects of Intercessory Prayer (STEP)
Showing all 5 trials